| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.827 | 0.002 | 0.827 | Macrophage migration inhibitory factor inhibitor | 0.767 0.002 CID_16850 | ||
| 0.713 | 0.006 | 0.713 | 12-Lipoxygenase inhibitor | 0.682 0.008 CID_16850 | ||
| 0.712 | 0.005 | 0.744 | Amyloid beta aggregation inhibitor | 0.744 0.005 CID_16850 | CID_16850 | |
| 0.699 | 0.008 | 0.699 | Aldehyde oxidase inhibitor | 0.688 0.009 CID_16850 | ||
| 0.688 | 0.014 | 0.688 | 15-Lipoxygenase inhibitor | 0.673 0.015 CID_16850 | ||
| 0.687 | 0.025 | 0.687 | Caspase 9 stimulant | 0.566 0.041 CID_16850 | ||
| 0.658 | 0.038 | 0.673 | Apoptosis agonist | 0.673 0.035 CID_16850 | CID_16850 | |
| 0.562 | 0.017 | 0.585 | 5 Hydroxytryptamine release inhibitor | 0.585 0.013 CID_16850 | CID_16850 | |
| 0.545 | 0.012 | 0.545 | Antiamyloidogenic | 0.481 0.018 CID_16850 | ||
| 0.547 | 0.017 | 0.585 | Histamine release inhibitor | 0.585 0.012 CID_16850 | CID_16850 | |
| 0.534 | 0.007 | 0.614 | Peroxidase inhibitor | 0.614 0.004 CID_16850 | CID_16850 | |
| 0.538 | 0.014 | 0.538 | Lipoxygenase inhibitor | 0.494 0.019 CID_16850 | ||
| 0.524 | 0.003 | 0.524 | Cystathionine beta-synthase inhibitor | 0.524 0.003 CID_16850 | ||
| 0.508 | 0.002 | 0.508 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.505 0.002 CID_16850 | ||
| 0.514 | 0.015 | 0.535 | Free radical scavenger | 0.535 0.013 CID_16850 | CID_16850 | |
| 0.538 | 0.039 | 0.538 | Transcription factor NF kappa B inhibitor | 0.516 0.042 CID_16850 | ||
| 0.484 | 0.004 | 0.504 | Sodium/bile acid cotransporter inhibitor | 0.504 0.004 CID_16850 | CID_16850 | |
| 0.494 | 0.021 | 0.527 | Antioxidant | 0.527 0.017 CID_16850 | CID_16850 | |
| 0.489 | 0.016 | 0.489 | Hypoxia-inducible factor 1 alpha inhibitor | 0.426 0.024 CID_16850 | ||
| 0.485 | 0.03 | 0.596 | GABA C receptor rho-3 antagonist | 0.596 0.008 CID_16850 | CID_16850 | |
| 0.441 | 0.032 | 0.441 | Caspase 3 stimulant | 0.408 0.042 CID_16850 | ||
| 0.376 | 0.011 | 0.376 | Amylase inhibitor | 0.359 0.012 CID_16850 | ||
| 0.377 | 0.014 | 0.377 | Melanin inhibitor | 0.332 0.018 CID_16850 | ||
| 0.427 | 0.065 | 0.467 | Antibacterial | 0.467 0.05 CID_16850 | CID_16850 | |
| 0.38 | 0.026 | 0.407 | Insulysin inhibitor | 0.407 0.021 CID_16850 | CID_16850 | |
| 0.38 | 0.026 | 0.38 | Antimitotic | 0.298 0.044 CID_16850 | ||
| 0.416 | 0.062 | 0.419 | Prostaglandin dehydrogenase inhibitor | 0.419 0.061 CID_16850 | CID_16850 | |
| 0.425 | 0.077 | 0.511 | Cyclophilin D inhibitor | 0.511 0.047 CID_16850 | CID_16850 | |
| 0.377 | 0.034 | 0.377 | DNA damaging | 0.368 0.036 CID_16850 | ||
| 0.349 | 0.013 | 0.349 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.347 0.013 CID_16850 | ||
| 0.378 | 0.043 | 0.378 | Vasodilator, coronary | 0.347 0.057 CID_16850 | ||
| 0.357 | 0.024 | 0.404 | 5 Hydroxytryptamine uptake stimulant | 0.404 0.014 CID_16850 | CID_16850 | |
| 0.338 | 0.005 | 0.442 | Estrogen receptor beta antagonist | 0.442 0.004 CID_16850 | CID_16850 | |
| 0.439 | 0.116 | 0.514 | Antiinflammatory | 0.514 0.082 CID_16850 | CID_16850 | |
| 0.35 | 0.032 | 0.372 | Nitric oxide antagonist | 0.372 0.029 CID_16850 | CID_16850 | |
| 0.319 | 0.005 | 0.415 | Estrogen antagonist | 0.415 0.004 CID_16850 | CID_16850 | |
| 0.345 | 0.037 | 0.345 | Superoxide dismutase inhibitor | 0.311 0.047 CID_16850 | ||
| 0.314 | 0.024 | 0.314 | DNA methylase inhibitor | 0.286 0.032 CID_16850 | ||
| 0.316 | 0.026 | 0.368 | Tyrosine 3 hydroxylase inhibitor | 0.368 0.013 CID_16850 | CID_16850 | |
| 0.278 | 0.003 | 0.323 | Toll-Like receptor 4 antagonist | 0.323 0.003 CID_16850 | CID_16850 | |
| 0.275 | 0.004 | 0.401 | Neuropeptide Y5 antagonist | 0.401 0.004 CID_16850 | CID_16850 | |
| 0.274 | 0.007 | 0.274 | Carbonic anhydrase XIII inhibitor | 0.255 0.008 CID_16850 | ||
| 0.284 | 0.021 | 0.284 | Tubulin antagonist | 0.17 0.049 CID_16850 | ||
| 0.373 | 0.126 | 0.373 | Alpha-glucosidase inhibitor | 0.33 0.145 CID_16850 | ||
| 0.249 | 0.012 | 0.27 | GABA C receptor rho-2 antagonist | 0.27 0.008 CID_16850 | CID_16850 | |
| 0.271 | 0.035 | 0.271 | P-glycoprotein inhibitor | 0.235 0.046 CID_16850 | ||
| 0.259 | 0.024 | 0.259 | Protein kinase stimulant | 0.253 0.025 CID_16850 | ||
| 0.255 | 0.023 | 0.255 | Monophenol monooxygenase inhibitor | 0.244 0.025 CID_16850 | ||
| 0.257 | 0.026 | 0.257 | MAO inhibitor | 0.235 0.031 CID_16850 | ||
| 0.248 | 0.017 | 0.27 | Topoisomerase I inhibitor | 0.27 0.014 CID_16850 | CID_16850 | |
| 0.256 | 0.035 | 0.293 | Neurotrophic factor enhancer | 0.293 0.02 CID_16850 | CID_16850 | |
| 0.25 | 0.032 | 0.253 | Nitric-oxide synthase stimulant | 0.253 0.03 CID_16850 | CID_16850 | |
| 0.218 | 0.005 | 0.243 | Glutathione S-transferase inhibitor | 0.243 0.004 CID_16850 | CID_16850 | |
| 0.301 | 0.09 | 0.301 | Calcium channel activator | 0.273 0.121 CID_16850 | ||
| 0.234 | 0.023 | 0.234 | MAO A inhibitor | 0.21 0.027 CID_16850 | ||
| 0.225 | 0.015 | 0.237 | Xanthine oxidase inhibitor | 0.237 0.014 CID_16850 | CID_16850 | |
| 0.219 | 0.011 | 0.242 | Carbonic anhydrase VI inhibitor | 0.242 0.009 CID_16850 | CID_16850 | |
| 0.222 | 0.017 | 0.25 | Interleukin 4 antagonist | 0.25 0.013 CID_16850 | CID_16850 | |
| 0.245 | 0.045 | 0.245 | Non-steroidal antiinflammatory agent | 0.23 0.052 CID_16850 | ||
| 0.343 | 0.143 | 0.343 | DNA polymerase beta inhibitor | 0.306 0.162 CID_16850 | ||
| 0.205 | 0.01 | 0.216 | TRPA1 agonist | 0.216 0.008 CID_16850 | CID_16850 | |
| 0.275 | 0.08 | 0.281 | Spasmolytic | 0.281 0.078 CID_16850 | CID_16850 | |
| 0.306 | 0.112 | 0.423 | Antiobesity | 0.423 0.057 CID_16850 | CID_16850 | |
| 0.22 | 0.029 | 0.22 | Heat shock protein 90 antagonist | 0.21 0.033 CID_16850 | ||
| 0.217 | 0.029 | 0.217 | NADPH oxidase inhibitor | 0.176 0.042 CID_16850 | ||
| 0.211 | 0.03 | 0.211 | Acetylcholinesterase inhibitor | 0.184 0.038 CID_16850 | ||
| 0.235 | 0.055 | 0.239 | Platelet adhesion inhibitor | 0.239 0.053 CID_16850 | CID_16850 | |
| 0.187 | 0.009 | 0.188 | Heat shock protein 70 antagonist | 0.188 0.009 CID_16850 | CID_16850 | |
| 0.217 | 0.04 | 0.218 | Heat shock protein 90 alpha antagonist | 0.218 0.04 CID_16850 | CID_16850 | |
| 0.19 | 0.014 | 0.251 | Histidine decarboxylase inhibitor | 0.251 0.009 CID_16850 | CID_16850 | |
| 0.226 | 0.052 | 0.231 | Hepatoprotectant | 0.231 0.049 CID_16850 | CID_16850 | |
| 0.18 | 0.008 | 0.224 | Aldose reductase inhibitor | 0.224 0.006 CID_16850 | CID_16850 | |
| 0.275 | 0.104 | 0.282 | Apoptosis antagonist | 0.282 0.098 CID_16850 | CID_16850 | |
| 0.185 | 0.014 | 0.206 | Papain-like protease (SARS coronavirus) inhibitor | 0.206 0.009 CID_16850 | CID_16850 | |
| 0.194 | 0.025 | 0.194 | MAO B inhibitor | 0.176 0.029 CID_16850 | ||
| 0.25 | 0.082 | 0.274 | Cardiotonic | 0.274 0.068 CID_16850 | CID_16850 | |
| 0.205 | 0.039 | 0.218 | Interferon gamma antagonist | 0.218 0.035 CID_16850 | CID_16850 | |
| 0.194 | 0.029 | 0.231 | Aldehyde dehydrogenase inhibitor | 0.231 0.021 CID_16850 | CID_16850 | |
| 0.184 | 0.021 | 0.184 | Carbonic anhydrase XV inhibitor | 0.177 0.023 CID_16850 | ||
| 0.182 | 0.019 | 0.202 | Carbonic anhydrase III inhibitor | 0.202 0.016 CID_16850 | CID_16850 | |
| 0.206 | 0.044 | 0.226 | Succinate dehydrogenase inhibitor | 0.226 0.032 CID_16850 | CID_16850 | |
| 0.192 | 0.035 | 0.201 | Mannose-6-phosphate isomerase inhibitor | 0.201 0.03 CID_16850 | CID_16850 | |
| 0.211 | 0.055 | 0.221 | Dual specificity phosphatase 3 inhibitor | 0.221 0.051 CID_16850 | CID_16850 | |
| 0.224 | 0.07 | 0.254 | RNA-directed DNA polymerase inhibitor | 0.254 0.047 CID_16850 | CID_16850 | |
| 0.196 | 0.043 | 0.203 | Lipid peroxidase inhibitor | 0.203 0.04 CID_16850 | CID_16850 | |
| 0.265 | 0.114 | 0.265 | Thyroid hormone antagonist | 0.244 0.127 CID_16850 | ||
| 0.272 | 0.12 | 0.275 | Thioredoxin glutathione reductase inhibitor | 0.275 0.118 CID_16850 | CID_16850 | |
| 0.234 | 0.087 | 0.234 | Hypoglycemic | 0.234 0.087 CID_16850 | ||
| 0.151 | 0.005 | 0.151 | Granulocyte macrophage colony stimulating factor agonist | 0.131 0.01 CID_16850 | ||
| 0.167 | 0.023 | 0.173 | Photosensitizer | 0.173 0.02 CID_16850 | CID_16850 | |
| 0.171 | 0.028 | 0.171 | Expectorant | 0.148 0.036 CID_16850 | ||
| 0.162 | 0.019 | 0.272 | Creatine kinase inhibitor | 0.272 0.005 CID_16850 | CID_16850 | |
| 0.147 | 0.006 | 0.204 | Vasopressin 1 antagonist | 0.204 0.005 CID_16850 | CID_16850 | |
| 0.256 | 0.115 | 0.256 | Thyroid hormone beta antagonist | 0.229 0.132 CID_16850 | ||
| 0.165 | 0.025 | 0.165 | Mucolytic | 0.151 0.032 CID_16850 | ||
| 0.225 | 0.086 | 0.225 | Vasodilator | 0.225 0.086 CID_16850 | ||
| 0.177 | 0.04 | 0.18 | Toll-Like receptor antagonist | 0.18 0.038 CID_16850 | CID_16850 | |
| 0.185 | 0.048 | 0.202 | Arachidonic acid antagonist | 0.202 0.031 CID_16850 | CID_16850 | |
| 0.18 | 0.042 | 0.18 | Alkaline phosphatase inhibitor | 0.164 0.051 CID_16850 | ||
| 0.17 | 0.033 | 0.17 | Cyclooxygenase 3 inhibitor | 0.163 0.038 CID_16850 | ||
| 0.158 | 0.022 | 0.166 | Topoisomerase II alpha inhibitor | 0.166 0.02 CID_16850 | CID_16850 | |
| 0.137 | 0.008 | 0.183 | Antidiuretic hormone antagonist | 0.183 0.005 CID_16850 | CID_16850 | |
| 0.169 | 0.04 | 0.169 | Toll-Like receptor 2 antagonist | 0.165 0.043 CID_16850 | ||
| 0.134 | 0.007 | 0.14 | Estradiol 17 beta-dehydrogenase inhibitor | 0.14 0.007 CID_16850 | CID_16850 | |
| 0.15 | 0.024 | 0.15 | Breast cancer-resistant protein inhibitor | 0.103 0.052 CID_16850 | ||
| 0.291 | 0.166 | 0.291 | DNA directed DNA polymerase inhibitor | 0.268 0.18 CID_16850 | ||
| 0.128 | 0.004 | 0.177 | Vasopressin 1B antagonist | 0.177 0.004 CID_16850 | CID_16850 | |
| 0.217 | 0.094 | 0.217 | Aryl hydrocarbon receptor agonist | 0.18 0.114 CID_16850 | ||
| 0.165 | 0.043 | 0.17 | Topoisomerase II inhibitor | 0.17 0.041 CID_16850 | CID_16850 | |
| 0.156 | 0.035 | 0.158 | 5-Lipoxygenase inhibitor | 0.158 0.035 CID_16850 | CID_16850 | |
| 0.176 | 0.056 | 0.265 | Diuretic | 0.265 0.028 CID_16850 | CID_16850 | |
| 0.12 | 0.003 | 0.199 | Bradykinin B2 receptor agonist | 0.199 0.002 CID_16850 | CID_16850 | |
| 0.157 | 0.041 | 0.157 | Cholesterol synthesis inhibitor | 0.157 0.041 CID_16850 | ||
| 0.174 | 0.06 | 0.197 | Protein-tyrosine phosphatase inhibitor | 0.197 0.048 CID_16850 | CID_16850 | |
| 0.128 | 0.016 | 0.149 | Estrogen receptor alpha antagonist | 0.149 0.012 CID_16850 | CID_16850 | |
| 0.284 | 0.171 | 0.313 | Calcium channel L-type activator | 0.313 0.146 CID_16850 | CID_16850 | |
| 0.125 | 0.013 | 0.18 | Estrogen agonist | 0.18 0.009 CID_16850 | CID_16850 | |
| 0.116 | 0.005 | 0.137 | Bcl-xL inhibitor | 0.137 0.004 CID_16850 | CID_16850 | |
| 0.127 | 0.018 | 0.127 | Dopamine D1 antagonist | 0.126 0.019 CID_16850 | ||
| 0.136 | 0.03 | 0.136 | Electron transport complex I inhibitor | 0.111 0.06 CID_16850 | ||
| 0.239 | 0.135 | 0.269 | Antithrombotic | 0.269 0.112 CID_16850 | CID_16850 | |
| 0.111 | 0.008 | 0.135 | Progesterone antagonist | 0.135 0.007 CID_16850 | CID_16850 | |
| 0.161 | 0.058 | 0.161 | CF transmembrane conductance regulator agonist | 0.157 0.064 CID_16850 | ||
| 0.148 | 0.046 | 0.172 | Protein-tyrosine phosphatase 1B inhibitor | 0.172 0.038 CID_16850 | CID_16850 | |
| 0.148 | 0.048 | 0.162 | Ca2+-transporting ATPase inhibitor | 0.162 0.021 CID_16850 | CID_16850 | |
| 0.127 | 0.03 | 0.162 | Androgen antagonist | 0.162 0.019 CID_16850 | CID_16850 | |
| 0.107 | 0.011 | 0.166 | Estrogen receptor beta agonist | 0.166 0.006 CID_16850 | CID_16850 | |
| 0.13 | 0.035 | 0.163 | DOPA decarboxylase inhibitor | 0.163 0.015 CID_16850 | CID_16850 | |
| 0.127 | 0.034 | 0.164 | GABA C receptor rho-1 antagonist | 0.164 0.016 CID_16850 | CID_16850 | |
| 0.111 | 0.019 | 0.115 | D-Ala-D-Ala ligase inhibitor | 0.115 0.016 CID_16850 | CID_16850 | |
| 0.166 | 0.076 | 0.167 | ATPase inhibitor | 0.167 0.076 CID_16850 | CID_16850 | |
| 0.167 | 0.077 | 0.176 | Dual specificity phosphatase inhibitor | 0.176 0.07 CID_16850 | CID_16850 | |
| 0.135 | 0.046 | 0.135 | Microtubule formation inhibitor | 0.132 0.049 CID_16850 | ||
| 0.093 | 0.005 | 0.148 | Vasopressin 1A antagonist | 0.148 0.004 CID_16850 | CID_16850 | |
| 0.098 | 0.012 | 0.098 | Glutamate (mGluR7) antagonist | 0.088 0.019 CID_16850 | ||
| 0.126 | 0.04 | 0.127 | Beta glucuronidase inhibitor | 0.127 0.039 CID_16850 | CID_16850 | |
| 0.178 | 0.095 | 0.178 | Pyruvate kinase inhibitor | 0.156 0.11 CID_16850 | ||
| 0.092 | 0.01 | 0.111 | Oxytocin antagonist | 0.111 0.009 CID_16850 | CID_16850 | |
| 0.09 | 0.01 | 0.09 | Transcription factor RelA inhibitor | 0.08 0.017 CID_16850 | ||
| 0.126 | 0.047 | 0.183 | GABA C receptor antagonist | 0.183 0.017 CID_16850 | CID_16850 | |
| 0.105 | 0.027 | 0.107 | Keratolytic | 0.107 0.027 CID_16850 | CID_16850 | |
| 0.149 | 0.071 | 0.149 | Cyclooxygenase inhibitor | 0.142 0.077 CID_16850 | ||
| 0.106 | 0.031 | 0.174 | Telomerase inhibitor | 0.174 0.017 CID_16850 | CID_16850 | |
| 0.179 | 0.106 | 0.184 | Angiogenesis stimulant | 0.184 0.103 CID_16850 | CID_16850 | |
| 0.08 | 0.009 | 0.08 | Ryanodine receptor antagonist | 0.064 0.028 CID_16850 | ||
| 0.112 | 0.041 | 0.124 | Antineoplastic antibiotic | 0.124 0.037 CID_16850 | CID_16850 | |
| 0.132 | 0.063 | 0.132 | Vanilloid 1 agonist | 0.124 0.079 CID_16850 | ||
| 0.095 | 0.027 | 0.106 | Carbonic anhydrase VA inhibitor | 0.106 0.023 CID_16850 | CID_16850 | |
| 0.096 | 0.029 | 0.117 | Lipase inhibitor | 0.117 0.019 CID_16850 | CID_16850 | |
| 0.095 | 0.028 | 0.115 | HIV-1 integrase inhibitor | 0.115 0.017 CID_16850 | CID_16850 | |
| 0.095 | 0.029 | 0.112 | Carbonic anhydrase V inhibitor | 0.112 0.023 CID_16850 | CID_16850 | |
| 0.078 | 0.012 | 0.093 | Mineralocorticoid receptor antagonist | 0.093 0.009 CID_16850 | CID_16850 | |
| 0.152 | 0.086 | 0.16 | Interleukin 6 antagonist | 0.16 0.075 CID_16850 | CID_16850 | |
| 0.133 | 0.067 | 0.133 | Cyclooxygenase 2 inhibitor | 0.131 0.069 CID_16850 | ||
| 0.076 | 0.01 | 0.096 | CXC chemokine 1 receptor antagonist | 0.096 0.005 CID_16850 | CID_16850 | |
| 0.102 | 0.037 | 0.102 | ATPase (Vacuolar H+) inhibitor | 0.091 0.053 CID_16850 | ||
| 0.093 | 0.028 | 0.115 | HIV-1 integrase (3'-Processing) inhibitor | 0.115 0.021 CID_16850 | CID_16850 | |
| 0.108 | 0.043 | 0.113 | Antineoplastic alkaloid | 0.113 0.041 CID_16850 | CID_16850 | |
| 0.133 | 0.068 | 0.133 | Cyclooxygenase 1 inhibitor | 0.124 0.076 CID_16850 | ||
| 0.098 | 0.036 | 0.105 | mTOR complex 2 inhibitor | 0.105 0.028 CID_16850 | CID_16850 | |
| 0.094 | 0.033 | 0.096 | Estrogen-related receptor beta agonist | 0.096 0.03 CID_16850 | CID_16850 | |
| 0.105 | 0.045 | 0.115 | Protein kinase C zeta inhibitor | 0.115 0.036 CID_16850 | CID_16850 | |
| 0.228 | 0.168 | 0.243 | Immunosuppressant | 0.243 0.154 CID_16850 | CID_16850 | |
| 0.195 | 0.136 | 0.208 | Streptokinase A inhibitor | 0.208 0.128 CID_16850 | CID_16850 | |
| 0.105 | 0.047 | 0.147 | Alcohol dehydrogenase inhibitor | 0.147 0.021 CID_16850 | CID_16850 | |
| 0.123 | 0.065 | 0.127 | Alkylator | 0.127 0.062 CID_16850 | CID_16850 | |
| 0.065 | 0.007 | 0.066 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.066 0.007 CID_16850 | CID_16850 | |
| 0.075 | 0.018 | 0.075 | Carbonic anhydrase XIV inhibitor | 0.068 0.021 CID_16850 | ||
| 0.104 | 0.051 | 0.14 | HIV-1 integrase (Overall Integration) inhibitor | 0.14 0.029 CID_16850 | CID_16850 | |
| 0.059 | 0.01 | 0.061 | DNA gyrase subunit A inhibitor | 0.061 0.01 CID_16850 | CID_16850 | |
| 0.067 | 0.018 | 0.067 | Glucose-6-phosphate translocase inhibitor | 0.058 0.026 CID_16850 | ||
| 0.184 | 0.136 | 0.194 | 5 Hydroxytryptamine release stimulant | 0.194 0.127 CID_16850 | CID_16850 | |
| 0.104 | 0.057 | 0.132 | Anabolic | 0.132 0.03 CID_16850 | CID_16850 | |
| 0.135 | 0.093 | 0.144 | Phospholipase A2 inhibitor | 0.144 0.081 CID_16850 | CID_16850 | |
| 0.075 | 0.033 | 0.094 | HIV-1 integrase (Strand Transfer) inhibitor | 0.094 0.025 CID_16850 | CID_16850 | |
| 0.053 | 0.012 | 0.075 | Somatostatin 5 antagonist | 0.075 0.009 CID_16850 | CID_16850 | |
| 0.066 | 0.025 | 0.085 | Sigma receptor antagonist | 0.085 0.019 CID_16850 | CID_16850 | |
| 0.071 | 0.031 | 0.076 | Xanthine dehydrogenase inhibitor | 0.076 0.027 CID_16850 | CID_16850 | |
| 0.132 | 0.093 | 0.132 | Cholinergic | |||
| 0.103 | 0.064 | 0.103 | Urease inhibitor | 0.102 0.065 CID_16850 | ||
| 0.147 | 0.109 | 0.148 | Neurotensin receptor agonist | 0.148 0.107 CID_16850 | CID_16850 | |
| 0.071 | 0.033 | 0.076 | Aromatase inhibitor | 0.076 0.03 CID_16850 | CID_16850 | |
| 0.047 | 0.009 | 0.059 | Liver X receptor beta antagonist | 0.059 0.006 CID_16850 | CID_16850 | |
| 0.045 | 0.008 | 0.052 | Estrogen-related receptor beta antagonist | 0.052 0.005 CID_16850 | CID_16850 | |
| 0.105 | 0.069 | 0.105 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.058 | 0.023 | 0.073 | CD45 antagonist | 0.073 0.014 CID_16850 | CID_16850 | |
| 0.131 | 0.096 | 0.163 | NOS3 expression enhancer | 0.163 0.061 CID_16850 | CID_16850 | |
| 0.055 | 0.021 | 0.06 | Microtubule stabilization | 0.06 0.014 CID_16850 | CID_16850 | |
| 0.054 | 0.023 | 0.057 | Carbonic anhydrase VII inhibitor | 0.057 0.021 CID_16850 | CID_16850 | |
| 0.077 | 0.046 | 0.094 | CDC25A inhibitor | 0.094 0.031 CID_16850 | CID_16850 | |
| 0.048 | 0.018 | 0.081 | Estrogen receptor alpha agonist | 0.081 0.012 CID_16850 | CID_16850 | |
| 0.093 | 0.063 | 0.121 | Prolactin inhibitor | 0.121 0.037 CID_16850 | CID_16850 | |
| 0.042 | 0.013 | 0.052 | Liver X receptor antagonist | 0.052 0.009 CID_16850 | CID_16850 | |
| 0.054 | 0.028 | 0.063 | Squalene epoxidase inhibitor | 0.063 0.018 CID_16850 | CID_16850 | |
| 0.046 | 0.02 | 0.085 | Dopamine D5 agonist | 0.085 0.005 CID_16850 | CID_16850 | |
| 0.059 | 0.033 | 0.06 | Acetyl-CoA transferase 2 inhibitor | 0.06 0.031 CID_16850 | CID_16850 | |
| 0.086 | 0.061 | 0.105 | Ornithine decarboxylase inhibitor | 0.105 0.039 CID_16850 | CID_16850 | |
| 0.063 | 0.038 | 0.086 | Androgen agonist | 0.086 0.021 CID_16850 | CID_16850 | |
| 0.066 | 0.043 | 0.069 | Aryl hydrocarbon receptor antagonist | 0.069 0.039 CID_16850 | CID_16850 | |
| 0.112 | 0.089 | 0.113 | DNA repair enzyme inhibitor | 0.113 0.087 CID_16850 | CID_16850 | |
| 0.061 | 0.038 | 0.077 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.077 0.026 CID_16850 | CID_16850 | |
| 0.034 | 0.012 | 0.039 | Potassium channel (Inward rectifier) 1 blocker | 0.039 0.007 CID_16850 | CID_16850 | |
| 0.05 | 0.028 | 0.069 | Neurotensin receptor antagonist | 0.069 0.021 CID_16850 | CID_16850 | |
| 0.031 | 0.009 | 0.034 | Complement factor 1r inhibitor | 0.034 0.007 CID_16850 | CID_16850 | |
| 0.041 | 0.02 | 0.049 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.049 0.016 CID_16850 | CID_16850 | |
| 0.193 | 0.172 | 0.208 | Cholesterol antagonist | 0.208 0.158 CID_16850 | CID_16850 | |
| 0.152 | 0.131 | 0.156 | Insulin sensitizer | 0.156 0.126 CID_16850 | CID_16850 | |
| 0.037 | 0.016 | 0.052 | ATP citrate lysase inhibitor | 0.052 0.007 CID_16850 | CID_16850 | |
| 0.055 | 0.035 | 0.055 | Alpha tubulin antagonist | |||
| 0.075 | 0.055 | 0.093 | Na+ K+ transporting ATPase inhibitor | 0.093 0.038 CID_16850 | CID_16850 | |
| 0.063 | 0.043 | 0.063 | Protease activated receptor antagonist | |||
| 0.055 | 0.035 | 0.071 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.071 0.021 CID_16850 | CID_16850 | |
| 0.101 | 0.084 | 0.125 | DNA polymerase I inhibitor | 0.125 0.065 CID_16850 | CID_16850 | |
| 0.09 | 0.076 | 0.098 | Phosphodiesterase 6D inhibitor | 0.098 0.057 CID_16850 | CID_16850 | |
| 0.048 | 0.034 | 0.057 | Cholesterol esterase inhibitor | 0.057 0.02 CID_16850 | CID_16850 | |
| 0.054 | 0.041 | 0.073 | Carbonic anhydrase VB inhibitor | 0.073 0.026 CID_16850 | CID_16850 | |
| 0.052 | 0.043 | 0.093 | Alcohol oxidase inhibitor | 0.093 0.02 CID_16850 | CID_16850 | |
| 0.048 | 0.039 | 0.064 | Prolyl endopeptidase inhibitor | 0.064 0.02 CID_16850 | CID_16850 | |
| 0.124 | 0.115 | 0.148 | Adenylate cyclase stimulant | 0.148 0.066 CID_16850 | CID_16850 | |
| 0.139 | 0.131 | 0.163 | Phospholipase C inhibitor | 0.163 0.082 CID_16850 | CID_16850 | |
| 0.022 | 0.015 | 0.034 | Estrone sulfatase inhibitor | 0.034 0.01 CID_16850 | CID_16850 | |
| 0.043 | 0.037 | 0.066 | Thymidylate synthase inhibitor | 0.066 0.014 CID_16850 | CID_16850 | |
| 0.067 | 0.062 | 0.075 | Glycine receptor agonist | 0.075 0.046 CID_16850 | CID_16850 | |
| 0.078 | 0.075 | 0.078 | Vanilloid agonist | |||
| 0.19 | 0.188 | 0.19 | Vasodilator, peripheral | |||
| 0.024 | 0.022 | 0.025 | Sodium/glucose cotransporter 2 inhibitor | 0.025 0.021 CID_16850 | CID_16850 | |
| 0.089 | 0.088 | 0.1 | AMP-activated protein kinase stimulant | 0.1 0.07 CID_16850 | CID_16850 | |
| 0.096 | 0.097 | 0.103 | M18 aspartyl aminopeptidase inhibitor | 0.103 0.088 CID_16850 | CID_16850 | |
| 0.047 | 0.048 | 0.062 | Protein kinase C eta inhibitor | 0.062 0.033 CID_16850 | CID_16850 | |
| 0.018 | 0.019 | 0.024 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.024 0.015 CID_16850 | CID_16850 | |
| 0.021 | 0.022 | 0.025 | Sigma 1 receptor antagonist | 0.025 0.019 CID_16850 | CID_16850 | |
| 0.102 | 0.104 | 0.104 | Bone formation stimulant | 0.104 0.102 CID_16850 | CID_16850 | |
| 0.042 | 0.046 | 0.06 | Glucose-6-phosphate isomerase inhibitor | 0.06 0.018 CID_16850 | CID_16850 | |
| 0.022 | 0.027 | 0.025 | Urotensin II agonist | 0.025 0.022 CID_16850 | CID_16850 | |
| 0.155 | 0.162 | 0.208 | Interleukin agonist | 0.208 0.113 CID_16850 | CID_16850 | |
| 0.029 | 0.038 | 0.034 | Opioid delta receptor agonist | 0.034 0.027 CID_16850 | CID_16850 | |
| 0.075 | 0.087 | 0.14 | Aminopeptidase B inhibitor | 0.14 0.042 CID_16850 | CID_16850 | |
| 0.059 | 0.071 | 0.073 | Glutamate (mGluR6) antagonist | 0.073 0.034 CID_16850 | CID_16850 | |
| 0.053 | 0.069 | 0.117 | Phenylalanine 4-hydroxylase inhibitor | 0.117 0.019 CID_16850 | CID_16850 | |
| 0.049 | 0.066 | 0.064 | Purinergic P2X1 antagonist | 0.064 0.038 CID_16850 | CID_16850 | |
| 0.04 | 0.058 | 0.049 | Topoisomerase II beta inhibitor | 0.049 0.035 CID_16850 | CID_16850 | |
| 0.045 | 0.064 | 0.072 | Fatty acid synthase inhibitor | 0.072 0.024 CID_16850 | CID_16850 | |
| 0.049 | 0.07 | 0.105 | Phosphofructokinase-1 inhibitor | 0.105 0.03 CID_16850 | CID_16850 | |
| 0.049 | 0.07 | 0.055 | Leukotriene C antagonist | 0.055 0.044 CID_16850 | CID_16850 | |
| 0.142 | 0.162 | 0.196 | Immunostimulant | 0.196 0.123 CID_16850 | CID_16850 | |
| 0.06 | 0.083 | 0.075 | GABA aminotransferase inhibitor | 0.075 0.054 CID_16850 | CID_16850 | |
| 0.034 | 0.057 | 0.039 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.036 CID_16850 | CID_16850 | |
| 0.16 | 0.184 | 0.202 | DNA synthesis inhibitor | 0.202 0.12 CID_16850 | CID_16850 | |
| 0.072 | 0.096 | 0.091 | NADH dehydrogenase inhibitor | 0.091 0.056 CID_16850 | CID_16850 | |
| 0.054 | 0.081 | 0.089 | Glutamate decarboxylase inhibitor | 0.089 0.037 CID_16850 | CID_16850 | |
| 0.055 | 0.088 | 0.079 | CYP2A6 inhibitor | 0.079 0.049 CID_16850 | CID_16850 | |
| 0.088 | 0.122 | 0.168 | Alpha-N-acetylglucosaminidase inhibitor | 0.168 0.046 CID_16850 | CID_16850 | |
| 0.036 | 0.076 | 0.056 | Aconitate hydratase inhibitor | 0.056 0.03 CID_16850 | CID_16850 | |
| 0.092 | 0.136 | 0.116 | Transcription factor STAT6 inhibitor | 0.116 0.067 CID_16850 | CID_16850 | |
| 0.024 | 0.073 | 0.032 | Protein kinase (CK2) beta inhibitor | 0.032 0.026 CID_16850 | CID_16850 | |
| 0.035 | 0.085 | 0.046 | Potassium channel (Inward rectifier) activator | 0.046 0.045 CID_16850 | CID_16850 | |
| 0.066 | 0.116 | 0.086 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.086 0.071 CID_16850 | CID_16850 | |
| 0.064 | 0.114 | 0.077 | MAP kinase kinase 7 inhibitor | 0.077 0.054 CID_16850 | CID_16850 | |
| 0.064 | 0.12 | 0.105 | Triose-phosphate isomerase inhibitor | 0.105 0.043 CID_16850 | CID_16850 | |
| 0.065 | 0.129 | 0.123 | GABA C receptor agonist | 0.123 0.047 CID_16850 | CID_16850 | |
| 0.063 | 0.13 | 0.113 | UDP-glucose 4-epimerase inhibitor | 0.113 0.049 CID_16850 | CID_16850 | |
| 0.03 | 0.113 | 0.058 | Carbamoyl phosphate synthetase inhibitor | 0.058 0.045 CID_16850 | CID_16850 | |
| 0.035 | 0.131 | 0.084 | Porphobilinogen synthase inhibitor | 0.084 0.044 CID_16850 | CID_16850 | |
| 0.081 | 0.193 | 0.117 | Cell wall synthesis inhibitor | 0.117 0.103 CID_16850 | CID_16850 | |
| 0.041 | 0.155 | 0.065 | Glutamate dehydrogenase inhibitor | 0.065 0.064 CID_16850 | CID_16850 | |
| 0.064 | 0.197 | 0.09 | Adenylate kinase inhibitor | 0.09 0.086 CID_16850 | CID_16850 | |
| 0.13 | 0.33 | 0.163 | 5 Hydroxytryptamine 3E antagonist | 0.163 0.159 CID_16850 | CID_16850 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |